Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	172,638	159,100	-	-	-	-
Enterprise Value	169,834	157,079	-	-	-	-
Last Close Price	1650.20	1512.33	-	-	-	-
PE Ratio	52.91	51.64	-	-	-	-
Forward PE	40.78	43.46	-	-	-	-
PS Ratio	15.85	15.65	-	-	-	-
PB Ratio	10.86	10.42	-	-	-	-
P/TBV Ratio	14.55	10.42	-	-	-	-
P/FCF Ratio	-	88.50	-	-	-	-
P/OCF Ratio	-	59.93	-	-	-	-
PEG Ratio	1.72	1.42	-	-	-	-
EV/Sales Ratio	15.59	15.45	-	-	-	-
EV/EBITDA Ratio	37.21	35.81	-	-	-	-
EV/EBIT Ratio	42.08	40.61	-	-	-	-
EV/FCF Ratio	-	87.37	-	-	-	-
Debt / Equity Ratio	0.00	0.01	0.02	0.06	0.09	0.07
Debt / EBITDA Ratio	0.01	0.02	0.09	0.22	0.27	0.24
Debt / FCF Ratio	-	0.05	0.31	1.19	-	-
Asset Turnover	-	0.63	0.60	0.57	0.58	-
Inventory Turnover	-	1.16	0.94	0.99	0.88	-
Quick Ratio	-	4.55	2.43	2.71	3.92	3.45
Current Ratio	-	6.30	3.79	4.08	5.74	4.68
Return on Equity (ROE)	-	21.88%	20.06%	16.64%	26.55%	-
Return on Assets (ROA)	-	15.04%	13.26%	11.47%	17.80%	-
Return on Capital (ROIC)	17.06%	16.92%	15.07%	12.70%	19.78%	-
Return on Capital Employed (ROCE)	-	24.82%	22.68%	19.78%	28.08%	23.50%
Earnings Yield	1.89%	1.94%	-	-	-	-
FCF Yield	1.13%	-	-	-	-
Dividend Yield	0.53%	0.58%	-	-	-	-
Payout Ratio	0.00%	23.19%	22.31%	40.31%	2.43%	47.63%
Total Shareholder Return	0.52%	0.58%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.